Heide Ford

Heide Ford

University of Colorado Denver

H-index: 52

North America-United States

About Heide Ford

Heide Ford, With an exceptional h-index of 52 and a recent h-index of 35 (since 2020), a distinguished researcher at University of Colorado Denver, specializes in the field of cancer biology, metastasis, EMT, developmental proteins and cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer

A novel MIRO2/MYO9B/RhoA signaling axis controls tumor cell invasion and metastasis

EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression

Genetic and Pharmacological Interruption of the SIX1/EYA2 Axis Impairs Leukemia Proliferation

SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma

Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer

In Vitro Phosphatase Assays for the Eya2 Tyrosine Phosphatase

Investigating the role of Eya3 in the regulation of NF-kB signaling and tumor progression in TNBC

Heide Ford Information

University

Position

School of Medicine

Citations(all)

10665

Citations(since 2020)

4322

Cited By

7803

hIndex(all)

52

hIndex(since 2020)

35

i10Index(all)

77

i10Index(since 2020)

63

Email

University Profile Page

University of Colorado Denver

Google Scholar

View Google Scholar Profile

Heide Ford Skills & Research Interests

cancer biology

metastasis

EMT

developmental proteins and cancer

Top articles of Heide Ford

Title

Journal

Author(s)

Publication Date

All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer

Connor J Hughes

Christopher Alderman

Arthur R Wolin

Kaiah M Fields

Rui Zhao

...

2024/3/28

A novel MIRO2/MYO9B/RhoA signaling axis controls tumor cell invasion and metastasis

Cancer Research

Dillon P Boulton

Connor J Hughes

Valentina Vaira

Ajita Jindal

Masoom Raza

...

2024/3/22

EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression

Neuro-oncology

Arthur R Wolin

Melanie Y Vincent

Taylor Hotz

Stephen C Purdy

Sheera R Rosenbaum

...

2023/12/1

Genetic and Pharmacological Interruption of the SIX1/EYA2 Axis Impairs Leukemia Proliferation

Blood

Waitman Aumann

Catherine Lavau

Dongdong Chen

Travis Reese

Joan Kim

...

2023/11/28

SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma

Nature Communications

Connor J Hughes

Kaiah M Fields

Etienne P Danis

Jessica Y Hsu

Deepika Neelakantan

...

2023/7/19

Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer

bioRxiv

Eric P Souto

Ping Gong

John D Landua

Ram Rajaram Srinivasan

Abhinaya Ganesan

...

2023

In Vitro Phosphatase Assays for the Eya2 Tyrosine Phosphatase

Christopher Alderman

Aaron Krueger

John Rossi

Heide L Ford

Rui Zhao

2023/12/27

Investigating the role of Eya3 in the regulation of NF-kB signaling and tumor progression in TNBC

Cancer Research

Connor J Hughes

Rebecca Mallo

Kaiah Fields

Hengbo Zhou

Annika Gustafson

...

2022/6/15

Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis

JCI insight

Cory Wilson

Tinne CJ Mertens

Pooja Shivshankar

Weizen Bi

Scott D Collum

...

2022/5/5

Structure–activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase

Protein Science

Jothi Anantharajan

Nithya Baburajendran

Grace Lin

Yong Yao Loh

Weijun Xu

...

2022/2

SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state

Cell reports

Jessica Y Hsu

Etienne P Danis

Stephanie Nance

Jenean H O'Brien

Annika L Gustafson

...

2022/2/1

Abstract IA020: Reprogramming of myogenic transcription factors in rhabdomyosarcoma

Clinical Cancer Research

Heide L Ford

Jessica Y Hsu

Etienne P Danis

Stephanie Nance

Jenean H O’Brien

...

2022/9/15

A SIX1/EYA2 Inhibitor Impairs CALM-AF10 and Jurkat Leukemia Cell Proliferation

Blood

Waitman Kurt Aumann

Catherine P Lavau

Dongdong Julie Chen

Amanda E Conway

Heide Ford

...

2021/11/23

Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe

Journal of Experimental Medicine

Guoxin Zhang

Zhen Dong

Ryan C Gimple

Arthur Wolin

Qiulian Wu

...

2021/10/7

VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk

Oncogene

Deguang Kong

Hengbo Zhou

Deepika Neelakantan

Connor J Hughes

Jessica Y Hsu

...

2021/2/4

Author Correction: Guidelines and definitions for research on epithelial–mesenchymal transition

Jing Yang

Parker Antin

Geert Berx

Cédric Blanpain

Thomas Brabletz

...

2021/12

The SIX1 homeobox Gene Is a Novel Therapeutic Target in CALM-AF10 Leukemogenesis

Blood

Waitman K Aumann

Catherine P Lavau

Amanda Harrington

Donald Tope

Amanda E Conway

...

2020/11/5

Novel Small Molecule Compound disrupts the SIX1/EYA2 Complex and Inhibits Breast Cancer Metastasis

The FASEB Journal

Hengbo Zhou

Melanie Blevins

Deguang Kong

Jessica Hsu

Matthew Galbraith

...

2020/4

Corrigendum to" The Eya phosphatase: Its unique role in cancer"[Int. J. Biochem. Cell Biol. 96 (2018) 165-170]

The international journal of biochemistry & cell biology

Hengbo Zhou

Lingdi Zhang

Rebecca L Vartuli

Heide L Ford

Rui Zhao

2020/10

Developing Novel Means to Inhibit Metastasis Through Targeting Tumor Heterogeneity and EMT

The FASEB Journal

Heide L Ford

Deguang Kong

Deepika Neelakantan

Hengbo Zhou

Connor Hughes

...

2020/4

See List of Professors in Heide Ford University(University of Colorado Denver)